116 related articles for article (PubMed ID: 38622884)
21. Overexpression of
Li B; Li X; Yang Q; Jiang Y; Zhang Q; Zhang J; Cui W; Xu F
Aging (Albany NY); 2024 Feb; 16(3):2953-2977. PubMed ID: 38329443
[TBL] [Abstract][Full Text] [Related]
22. The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in
Wang Z; Zhang L; Xu W; Li J; Liu Y; Zeng X; Zhong M; Zhu Y
J Inflamm Res; 2022; 15():649-667. PubMed ID: 35140497
[TBL] [Abstract][Full Text] [Related]
23. Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma.
Luo X; Feng L; Xu W; Bai X; Wu M
Evol Bioinform Online; 2021; 17():11769343211009898. PubMed ID: 33911849
[TBL] [Abstract][Full Text] [Related]
24. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma.
Luo Y; Zhang S; Xie H; Su Q; He S; Lei Z
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):51-61. PubMed ID: 38279482
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis.
Wang XJ; Gao J; Wang Z; Yu Q
Front Cell Dev Biol; 2021; 9():641840. PubMed ID: 33681226
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
[TBL] [Abstract][Full Text] [Related]
27. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
Front Oncol; 2021; 11():639600. PubMed ID: 33968738
[TBL] [Abstract][Full Text] [Related]
28. Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
Chen Z; Yang X; Bi G; Liang J; Hu Z; Zhao M; Li M; Lu T; Zheng Y; Sui Q; Yang Y; Zhan C; Jiang W; Wang Q; Tan L
Int J Biol Sci; 2020; 16(12):2205-2219. PubMed ID: 32549766
[No Abstract] [Full Text] [Related]
29. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
PeerJ; 2020; 8():e9530. PubMed ID: 32775050
[TBL] [Abstract][Full Text] [Related]
30. H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma.
Fan T; Zhu M; Muhammad S; Xiao C; Li S; Tian H; Liu Y; Xue L; Zheng B; Li C; He J
Respir Res; 2023 May; 24(1):122. PubMed ID: 37131252
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing.
Yang J; Liu K; Yang L; Ji J; Qin J; Deng H; Wang Z
Front Immunol; 2023; 14():1174762. PubMed ID: 37287976
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
33. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Deng H; Hang Q; Shen D; Zhang Y; Chen M
Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
[TBL] [Abstract][Full Text] [Related]
34. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
35. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
36. Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis.
Zhang Q; Liu Y; Wang X; Zhang C; Hou M; Liu Y
Front Immunol; 2023; 14():1184167. PubMed ID: 37675100
[TBL] [Abstract][Full Text] [Related]
37. Transcriptomic analysis reveals the potential biological mechanism of AIS and lung adenocarcinoma.
Qin RX; Yang Y; Chen JF; Huang LJ; Xu W; Qin QC; Liang XJ; Lai XY; Huang XY; Xie MS; Chen L
Front Neurol; 2023; 14():1119160. PubMed ID: 37265472
[TBL] [Abstract][Full Text] [Related]
38. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.
Yi X; Luo L; Zhu Y; Deng H; Liao H; Shen Y; Zheng Y
Cancer Cell Int; 2022 Oct; 22(1):324. PubMed ID: 36266702
[TBL] [Abstract][Full Text] [Related]
39. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract][Full Text] [Related]
40. RAB11FIP1: An Indicator for Tumor Immune Microenvironment and Prognosis of Lung Adenocarcinoma from a Comprehensive Analysis of Bioinformatics.
Zhang W; Chen T; Liu J; Yu S; Liu L; Zheng M; Liu Y; Zhang H; Bian T; Zhao X
Front Genet; 2021; 12():757169. PubMed ID: 34764984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]